Ethchlorvynol |
Placidyl |
HSDB 3079 |
ETHYCHLORVYNOL |
ROERIDORM |
MOLPORT-004-285-854 |
A 71 |
ETHCLORVYNOL |
3-(BETA-CHLOROVINYL)-1-PENTYN-3-OL |
C07833 |
113-18-8 |
1-CHLORO-3-ETHYLPENT-1-EN-4-YN-3-OL |
DEA NO. 2540 |
SERENSIL |
10035 |
1-PENTEN-4-YN-3-OL, 1-CHLORO-3-ETHYL- |
(E)-1-CHLORO-3-ETHYLPENT-1-EN-4-YN-3-OL |
NSC 30372 |
BETA-CHLORVINYL ETHYL ETHYNYL CARBINOL |
NROMOSON |
ETHOCHLORVYNOL |
NORMONSON |
LS-102223 |
D00704 |
NOSTEL |
ETHCHLORVYNOLUM |
NORMOSON |
CID5281077 |
ETCLORVINOL [INN-SPANISH] |
ALVINOL |
DAP000163 |
1-CHLORO-3-ETHYLPENT-1-4-YN-3-OL |
3281 |
BETA-CHLOROVINYL ETHYL ETHYNYL CARBINOL |
ETHYL BETA-CHLOROVINYL ETHYNYL CARBINOL |
5-CHLORO-3-ETHYLPENT-1-YN-4-EN-3-OL |
AC1Q3HC3 |
DB00189 |
CHEBI:4882 |
1-CHLORO-3-ETHYL-1-PENTEN-4-YN-3-OL |
AETHYL-CHLORVYNOL |
ETHCHLORVINYL |
SERENIL |
ETHCHLORVINOL |
AR-1I7766 |
C7H9CLO |
SERENSILOLINE |
AC1NQXZT |
NORMOSAN |
ETHCHLOROVYNOL |
ETCHLORVINOLO |
ETHCHLORVYNOLUM [INN-LATIN] |
ETCLORVINOL |
SERENESIL |
PLACIDYL (TN) |
ARVYNOL |
AI3-23721 |
BRN 1702245 |
PLACIDIL |
ETHCHLORVYNOL [USAN:INN:BAN] |
ETHCHLORVYNOL (JAN/USP/INN) |
UNII-6EIM3851UZ |
I14-17465 |
(E)-1-CHLORO-3-ETHYL-PENT-1-EN-4-YN-3-OL |
(1E)-1-CHLORO-3-ETHYLPENT-1-EN-4-YN-3-OL |
X2131 |
FT-0667985 |
1-CHLORO-3-ETHYL-1-PENTEN-4-YN-3-OL # |
OR203741 |
OR039393 |
AN-22729 |
1-CHLORO-3-ETHYL-PENT-1-EN-4-YN-3-OL |
AKOS015903758 |
ETHCHLORVYNOL CIV (0.7 ML) |
ZEHYJZXQEQOSON-AATRIKPKSA-N |
GTPL7180 |
SCHEMBL113591 |
SCHEMBL113589 |
ETHYL .BETA.-CHLOROVINYL ETHYNYL CARBINOL |
.BETA.-CHLOROVINYL ETHYL ETHYNYL CARBINOL |
3-(.BETA.-CHLOROVINYL)-1-PENTYN-3-OL |
PLACIDYLREG |
5281077 |
Placidyl Cap 750mg |
Placidyl Cap 500mg |
Placidyl Cap 200mg |
β-chlorovinyl ethyl ethynyl carbinol |
ethyl β-chlorovinyl ethynyl carbinol |
3-(β-chlorovinyl)-1-pentyn-3-ol |
Drug Categories | therapeutic uses |
Drug Categories | psycholeptics |
Drug Categories | physiological effects of drugs |
Drug Categories | pharmacologic actions |
Drug Categories | organic chemicals |
Drug Categories | nervous system |
Drug Categories | hypnotics and sedatives |
Drug Categories | chlorohydrins |
Drug Categories | chemical actions and uses |
Drug Categories | central nervous system depressants |
Drug Categories | central nervous system agents |
Drug Categories | alcohols |
Drug Groups | withdrawn |
Drug Groups | illicit |
Drug Groups | approved |
Drug Type | small molecule |
antagonist |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
antagonist |
positive allosteric modulator |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
n/a |
Mechanism of Interaction | GABA-A receptor; anion channel positive modulator |
Direct Interaction | yes |
ETHCHLORVYNOL | DrugBank Drug Name |
1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol | Drug Synonym |
1-chloro-3-ethyl-1-penten-4-yn-3-ol | Drug Synonym |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | illicit |
C07833 | Drug Synonym |
ETHCHLORVYNOL | pubchem_primary_name |
5281077 | PubChem CID |
UNII-6EIM3851UZ | Drug Synonym |
ETHCHLORVYNOL (JAN/USP/INN) | Drug Synonym |
ETHCHLORVYNOL [USAN:INN:BAN] | Drug Synonym |